Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer

R. Charles Coombes; Judith M. Bliss; Marc Espie; Frans L. G. Erdkamp; Jacob Wals; Alejandro Tres; Michel Marty; Robert E. Coleman; Nicole Tubiana-Mathieu; Marinus O. den Boer; Andrew Wardley; Lucy S. Kilburn; Derek Cooper; Marina W. K. Thomas; Justine A. Reise; Katie Wilkinson; Pierre Hupperets

doi:10.1200/JCO.2010.32.7254

Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer

R. Charles Coombes, Judith M. Bliss, Marc Espie, Frans L. G. Erdkamp, Jacob Wals, Alejandro Tres, Michel Marty, Robert E. Coleman, Nicole Tubiana-Mathieu, Marinus O. den Boer, Andrew Wardley, Lucy S. Kilburn, Derek Cooper, Marina W. K. Thomas, Justine A. Reise, Katie Wilkinson, Pierre Hupperets

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3247-3254
Journal	Journal of Clinical Oncology
Volume	29
Issue number	24
DOIs	https://doi.org/10.1200/JCO.2010.32.7254
Publication status	Published - 20 Aug 2011

Access to Document

10.1200/JCO.2010.32.7254

Cite this

Coombes, R. C., Bliss, J. M., Espie, M., Erdkamp, F. L. G., Wals, J., Tres, A., Marty, M., Coleman, R. E., Tubiana-Mathieu, N., den Boer, M. O., Wardley, A., Kilburn, L. S., Cooper, D., Thomas, M. W. K., Reise, J. A., Wilkinson, K., & Hupperets, P. (2011). Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. Journal of Clinical Oncology, 29(24), 3247-3254. https://doi.org/10.1200/JCO.2010.32.7254

Coombes, R. Charles ; Bliss, Judith M. ; Espie, Marc ; Erdkamp, Frans L. G. ; Wals, Jacob ; Tres, Alejandro ; Marty, Michel ; Coleman, Robert E. ; Tubiana-Mathieu, Nicole ; den Boer, Marinus O. ; Wardley, Andrew ; Kilburn, Lucy S. ; Cooper, Derek ; Thomas, Marina W. K. ; Reise, Justine A. ; Wilkinson, Katie ; Hupperets, Pierre. / Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. In: Journal of Clinical Oncology. 2011 ; Vol. 29, No. 24. pp. 3247-3254.

@article{d7147be12cb5479db32be4f91ea81290,

title = "Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer",

author = "Coombes, {R. Charles} and Bliss, {Judith M.} and Marc Espie and Erdkamp, {Frans L. G.} and Jacob Wals and Alejandro Tres and Michel Marty and Coleman, {Robert E.} and Nicole Tubiana-Mathieu and {den Boer}, {Marinus O.} and Andrew Wardley and Kilburn, {Lucy S.} and Derek Cooper and Thomas, {Marina W. K.} and Reise, {Justine A.} and Katie Wilkinson and Pierre Hupperets",

year = "2011",

month = aug,

day = "20",

doi = "10.1200/JCO.2010.32.7254",

language = "English",

volume = "29",

pages = "3247--3254",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "24",

}

Coombes, RC, Bliss, JM, Espie, M, Erdkamp, FLG, Wals, J, Tres, A, Marty, M, Coleman, RE, Tubiana-Mathieu, N, den Boer, MO, Wardley, A, Kilburn, LS, Cooper, D, Thomas, MWK, Reise, JA, Wilkinson, K & Hupperets, P 2011, 'Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer', Journal of Clinical Oncology, vol. 29, no. 24, pp. 3247-3254. https://doi.org/10.1200/JCO.2010.32.7254

Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. / Coombes, R. Charles; Bliss, Judith M.; Espie, Marc; Erdkamp, Frans L. G.; Wals, Jacob; Tres, Alejandro; Marty, Michel; Coleman, Robert E.; Tubiana-Mathieu, Nicole; den Boer, Marinus O.; Wardley, Andrew; Kilburn, Lucy S.; Cooper, Derek; Thomas, Marina W. K.; Reise, Justine A.; Wilkinson, Katie; Hupperets, Pierre.

In: Journal of Clinical Oncology, Vol. 29, No. 24, 20.08.2011, p. 3247-3254.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer

AU - Coombes, R. Charles

AU - Bliss, Judith M.

AU - Espie, Marc

AU - Erdkamp, Frans L. G.

AU - Wals, Jacob

AU - Tres, Alejandro

AU - Marty, Michel

AU - Coleman, Robert E.

AU - Tubiana-Mathieu, Nicole

AU - den Boer, Marinus O.

AU - Wardley, Andrew

AU - Kilburn, Lucy S.

AU - Cooper, Derek

AU - Thomas, Marina W. K.

AU - Reise, Justine A.

AU - Wilkinson, Katie

AU - Hupperets, Pierre

PY - 2011/8/20

Y1 - 2011/8/20

U2 - 10.1200/JCO.2010.32.7254

DO - 10.1200/JCO.2010.32.7254

M3 - Article

VL - 29

SP - 3247

EP - 3254

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 24

ER -